The role of adaptive immunity in organophosphate induced CNS injury
适应性免疫在有机磷诱导的中枢神经系统损伤中的作用
基本信息
- 批准号:10629511
- 负责人:
- 金额:$ 24.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccidentsAcidsAcuteAdverse effectsAffectAlbuminsAmino AcidsAntibodiesAntibody FormationAntidotesAntigensAreaAstrocytesAutoimmuneAutoimmune DiseasesB-LymphocytesBiological MarkersBloodBrainCellsCentral Nervous SystemChemical WarfareChemicalsChlorpyrifosChronicChronic Fatigue SyndromeClassificationCognitiveCross ReactionsDataDevelopmentDiseaseEncephalitisEnvironmental ExposureExposure toFutureGasesHeadacheHealthHealth systemHumanImmuneImmune System DiseasesImmune TargetingImmune responseImmune systemImmunologic StimulationIndividualIntoxicationIranIraqMass Spectrum AnalysisMediatingMethodsMicrogliaMorbidity - disease rateMusMuscle FatigueMuscle WeaknessNeuronsOralOrganophosphatesPeripheralPeripheral Nervous SystemPersian Gulf SyndromePesticidesPlasmaPoisonPoisoningPopulationProteinsQuality of lifeReportingRoleSarinSecuritySubwaySydenham ChoreaSymptomsSyriaT memory cellT-Cell ActivationTestingTokyoToxic effectTyrosineVeteransWomanWorkadaptive immune responseadaptive immunityadductcentral nervous system injurychemical threatexperienceimmune activationimprovedin vivoinnovationmedical countermeasuremouse modelnerve agentnerve gasneuroinflammationneurotoxicitynovelorganophosphate poisoningpesticide poisoningprogramspyrethroidresponsestandard of caretherapy developmenttoxic organophosphate insecticide exposure
项目摘要
Chlorpyrifos (CPF) is an organophosphate (OP) pesticide, classified as a chemical threat agent by the
Department of Homeland Security because it can cause neurotoxicity if released into the civilian populations.
Under these circumstances, CPF and similar OP chemicals have a potential to cause long-term chronic multi
symptom illnesses (CMI), such as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). To date,
many victims of the Tokyo subway sarin gas attack are still experiencing chronic health problems consisting of
cognitive difficulties, headaches, muscle weaknesses and fatigue, which negatively impact their quality of life.
Such symptoms are reported by individuals exposed to OP pesticides and are thought to be caused by
maladaptive immune responses7. As such, this proposal will investigate the role of CPF in maladaptive
immune responses to develop future approaches that mitigate long-term morbidity associated with CMI.
Ordinarily, a small chemical is not antigenic, but when it forms adducts with endogenous proteins, it can be
recognized by the immune system as a foreign threat agent and provoke an adaptive immune response. Our
prior work in this area shows that certain pesticide metabolites can form adducts with proteins and then elicit
an adaptive immune response, activating T- and B-cells that ultimately contribute to the production of
antibodies against them and corresponding with brain inflammation. Accounts of acute CPF poisoning in
humans support this notion by showing that CPF or CPF-oxon (CPO) can form adducts on several amino acid
residues in human albumin, which are considered biomarkers of OP exposure. However, it is unknown whether
these CPF/CPO-protein adducts have a role in activating the immune system. We therefore hypothesize that
CPF/CPO-protein adducts formed in vivo after CPF exposure can activate T-cell and B-cell responses,
resulting in antibody production. We propose that CPF-protein specific antibodies may cross-react with brain
proteins and contribute to the development of chronic autoimmune disorders. The proposed work builds upon
an existing scientific premise of pesticide-mediated maladaptive immune responses. These studies will
characterize whether acute CPF administration stimulates immune cells and whether this corresponds with
activation of the microglia and astroglia and neuroinflammation after CPF exposure. We will determine whether
brain immune activation is associated with formation of CPF/CPO-protein adducts. We will examine the
presence of immune cells that recognize CPF/CPO-modified proteins and antibodies against them to
determine if blood antibodies can cross-react with brain proteins. Understanding the mechanisms of OP-
induced CMI will facilitate the development of countermeasure efforts that target the immune system in order to
minimize long-term morbidity associated with such illnesses in civilian populations following a mass chemical
attack with CPF or similar chemicals.
Chlorpyrifos(CPF)是一种有机磷酸盐(OP)农药,被归类为化学威胁剂
国土安全部是因为如果释放到平民人口中,可能会引起神经毒性。
在这种情况下,CPF和类似的OP化学物质有可能引起长期慢性多种
症状疾病(CMI),例如肌力性脑脊髓炎/慢性疲劳综合征(ME/CFS)。迄今为止,
东京地铁沙林气体攻击的许多受害者仍在遇到慢性健康问题,包括
认知困难,头痛,肌肉弱点和疲劳,对他们的生活质量产生负面影响。
暴露于Op农药的人报告了此类症状,被认为是由
适应性免疫反应7。因此,该提案将调查CPF在适应不良中的作用
对开发未来方法的免疫反应,以减轻与CMI相关的长期发病率。
通常,一种小化学物质不是抗原性的,但是当它与内源性蛋白形成加合物时,可以是
被免疫系统认可为外国威胁代理,并引起适应性免疫反应。我们的
该领域的先前工作表明,某些农药代谢物可以用蛋白质形成加合物,然后引起
自适应免疫反应,激活T型和B细胞,最终有助于产生
针对它们的抗体,与大脑炎症相对应。急性CPF中毒的帐户
人类通过表明CPF或CPF-OXON(CPO)可以在几种氨基酸上形成加合物来支持这一概念
人白蛋白中的残留物被认为是OP暴露的生物标志物。但是,未知是否
这些CPF/CPO蛋白加合物在激活免疫系统中起作用。因此,我们假设
CPF/CPO蛋白加合物在CPF暴露后在体内形成的加合物可以激活T细胞和B细胞反应,即
导致抗体产生。我们建议CPF蛋白特异性抗体可能与脑反应
蛋白质并有助于慢性自身免疫性疾病的发展。拟议的工作建立在
农药介导的不良适应性免疫反应的现有科学前提。这些研究会
表征急性CPF给药是否刺激免疫细胞,以及是否与
CPF暴露后,小胶质细胞和星形胶质细胞的激活以及神经炎症。我们将确定是否
脑免疫激活与CPF/CPO蛋白质加合物的形成有关。我们将检查
存在识别CPF/CPO修饰蛋白的免疫细胞和针对它们的抗体
确定血液抗体是否可以与脑蛋白交叉反应。了解操作的机制
诱导的CMI将促进针对免疫系统的对策努力的发展
最小化与这种疾病相关的长期发病率在大众化学后的平民种群中
用CPF或类似化学物质攻击。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laila Abdullah其他文献
Laila Abdullah的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laila Abdullah', 18)}}的其他基金
Cerebrovascular contributions to APOE4-mediated brain bioenergetic deficits in Alzheimer's disease
脑血管对 APOE4 介导的阿尔茨海默病脑生物能缺陷的影响
- 批准号:
10739352 - 财政年份:2023
- 资助金额:
$ 24.43万 - 项目类别:
The effects of APOE4 on carnitine/acylcarnitine mediated bioenergetic deficits in Alzheimer's disease
APOE4 对肉碱/酰基肉碱介导的阿尔茨海默病生物能缺陷的影响
- 批准号:
10370296 - 财政年份:2021
- 资助金额:
$ 24.43万 - 项目类别:
Long term assessment of neurological effects after red tide exposure
赤潮暴露后神经系统影响的长期评估
- 批准号:
10155490 - 财政年份:2020
- 资助金额:
$ 24.43万 - 项目类别:
Influence of APOE genotypes on blood brain barrier transport of DHA by mfsd2a in Alzheimer's Disease
APOE基因型对阿尔茨海默病中mfsd2a血脑屏障转运DHA的影响
- 批准号:
10292958 - 财政年份:2019
- 资助金额:
$ 24.43万 - 项目类别:
Identifying APOE related lipid biomarkers for diagnosing chronic neurocognitive deficits in TBI patients
鉴定用于诊断 TBI 患者慢性神经认知缺陷的 APOE 相关脂质生物标志物
- 批准号:
10454875 - 财政年份:2019
- 资助金额:
$ 24.43万 - 项目类别:
Influence of APOE genotypes on blood brain barrier transport of DHA by mfsd2a in Alzheimer's Disease
APOE基因型对阿尔茨海默病中mfsd2a血脑屏障转运DHA的影响
- 批准号:
9663028 - 财政年份:2019
- 资助金额:
$ 24.43万 - 项目类别:
Influence of APOE genotypes on blood brain barrier transport of DHA by mfsd2a in Alzheimer's Disease
APOE基因型对阿尔茨海默病中mfsd2a血脑屏障转运DHA的影响
- 批准号:
10515657 - 财政年份:2019
- 资助金额:
$ 24.43万 - 项目类别:
Identifying APOE related lipid biomarkers for diagnosing chronic neurocognitive deficits in TBI patients
鉴定用于诊断 TBI 患者慢性神经认知缺陷的 APOE 相关脂质生物标志物
- 批准号:
9910069 - 财政年份:2019
- 资助金额:
$ 24.43万 - 项目类别:
Identifying APOE related lipid biomarkers for diagnosing chronic neurocognitive deficits in TBI patients
鉴定用于诊断 TBI 患者慢性神经认知缺陷的 APOE 相关脂质生物标志物
- 批准号:
10614552 - 财政年份:2019
- 资助金额:
$ 24.43万 - 项目类别:
Influence of APOE genotypes on blood brain barrier transport of DHA by mfsd2a in Alzheimer's Disease
APOE基因型对阿尔茨海默病中mfsd2a血脑屏障转运DHA的影响
- 批准号:
10043826 - 财政年份:2019
- 资助金额:
$ 24.43万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
急性髓系白血病细胞脂肪酸代谢异质性及其调控机制
- 批准号:82370180
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
新型构象稳定的大环类FLT3抑制剂的设计、合成与抑制门控卡口氨基酸F691L突变导致的急性髓性白血病耐药活性研究
- 批准号:82373710
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
衣康酸介导KDM3A/H3K9/PARP9轴调控DNA损伤修复在急性胰腺炎腺泡细胞坏死中的作用和机制研究
- 批准号:82370653
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
支链氨基酸转氨酶1在核心结合因子急性髓细胞白血病中的异常激活与促进白血病发生的分子机制研究
- 批准号:82370178
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Broad spectrum inhibitors of paramyxovirus envelope proteins
副粘病毒包膜蛋白的广谱抑制剂
- 批准号:
10634368 - 财政年份:2023
- 资助金额:
$ 24.43万 - 项目类别:
Lipid and metabolic mechanisms responsible for phosgene and phosphorus trichloride exposure toxicity
导致光气和三氯化磷暴露毒性的脂质和代谢机制
- 批准号:
10708475 - 财政年份:2023
- 资助金额:
$ 24.43万 - 项目类别:
IND-enabling development of Radioprotectin 1: a dual GI/HE radiation mitigator
Radioprotectin 1 的 IND 开发:双重 GI/HE 辐射缓解剂
- 批准号:
10794519 - 财政年份:2023
- 资助金额:
$ 24.43万 - 项目类别:
Triterpenoids in mitigation of radiation induced acute or delayed inflammation
三萜类化合物可减轻辐射引起的急性或迟发性炎症
- 批准号:
10852214 - 财政年份:2022
- 资助金额:
$ 24.43万 - 项目类别:
Halolipid-Neutrophil Extracellular Trap Axis in Halogen Lung Injury
卤素肺损伤中的氟脂-中性粒细胞胞外俘获轴
- 批准号:
10685387 - 财政年份:2022
- 资助金额:
$ 24.43万 - 项目类别: